Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS

Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus

(2014) Pingzheng Mo et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients

(2014) Raquel Lima de Figueiredo Teixeira et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients

(2014) Getnet Yimer et al.   PLoS One

Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity

(2014) Neha Singla et al.   TUBERCULOSIS

The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients

(2014) Camila Zaverucha-do-Valle et al.   TUBERCULOSIS

N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients

(2013) N. P. C. Santos et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India

(2013) Vinod H Gupta et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Anti-Tuberculosis Drug Induced Hepatotoxicity among TB/HIV Co-Infected Patients at Jimma University Hospital, Ethiopia: Nested Case-Control Study

(2013) Alima Hassen Ali et al.   PLoS One

Genetic Interaction between NAT2, GSTM1, GSTT1, CYP2E1, and Environmental Factors Is Associated with Adverse Reactions to Anti-Tuberculosis Drugs

(2012) Gustavo N. O. Costa et al.   Molecular Diagnosis & Therapy

Pharmacogenetic Study of Drug-Metabolising Enzyme Polymorphisms on the Risk of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis

(2012) Yu Cai et al.   PLoS One

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

(2011) Diane V. Havlir et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients

(2011) Getnet Yimer et al.   PLoS One

Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection

(2010) J. L. Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antituberculosis drug-induced hepatotoxicity: a comparison between patients with and without human immunodeficiency virus seropositivity

(2010) Natalia Saldanha Magalhães Coca et al.   Revista da Sociedade Brasileira de Medicina Tropical

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

(2008) L. G. Possuelo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases

(2008) Hoda A. Makhlouf et al.   Hepatology International

HIV-Associated Tuberculosis: Diagnostic and Treatment Challenges

(2008) Wafaa El-Sadr et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon

(2008) Isidore Sieleunou et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review

(2007) Alma Tostmann et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY